openPR Logo

Press Releases from Familial Adenomatous Polyposis (FAP) Therapeutics- Pharma Proff (1 total)

Familial Adenomatous Polyposis (FAP) Therapeutics- Pipeline Analysis 2018

Familial adenomatous polyposis (FAP) is a genetic disorder, characterized by the development of adenomatous colon polyps in the intestinal tract, resulting in colon cancer. The disease is diagnosed when more than 100 adenomatous colon polyps are developed in a person. Download the sample report at: https://www.pharmaproff.com/request-sample/1025 A person with FAP is at a high risk of developing cancer of small intestines or stomach. This disease is categorized into three types including attenuated